ES2145075T3 - Nuevos derivados fibrinoliticos de la uroquinasa, plasmidos para su preparacion y tromboliticos que los contienen. - Google Patents

Nuevos derivados fibrinoliticos de la uroquinasa, plasmidos para su preparacion y tromboliticos que los contienen.

Info

Publication number
ES2145075T3
ES2145075T3 ES94108872T ES94108872T ES2145075T3 ES 2145075 T3 ES2145075 T3 ES 2145075T3 ES 94108872 T ES94108872 T ES 94108872T ES 94108872 T ES94108872 T ES 94108872T ES 2145075 T3 ES2145075 T3 ES 2145075T3
Authority
ES
Spain
Prior art keywords
uroquinase
fibrinolitic
plasmids
contain
thrombolitics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94108872T
Other languages
English (en)
Spanish (es)
Inventor
Gerd Josef Prof Dr Steffens
Stephan Dr Wnendt
Johannes Dr Schneider
Regina Dr Heinzel-Wieland
Derek John Dr Saunders
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Chemie Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH, Chemie Gruenenthal GmbH filed Critical Gruenenthal GmbH
Application granted granted Critical
Publication of ES2145075T3 publication Critical patent/ES2145075T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES94108872T 1993-07-15 1994-06-09 Nuevos derivados fibrinoliticos de la uroquinasa, plasmidos para su preparacion y tromboliticos que los contienen. Expired - Lifetime ES2145075T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4323754A DE4323754C1 (de) 1993-07-15 1993-07-15 Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung

Publications (1)

Publication Number Publication Date
ES2145075T3 true ES2145075T3 (es) 2000-07-01

Family

ID=6492909

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94108872T Expired - Lifetime ES2145075T3 (es) 1993-07-15 1994-06-09 Nuevos derivados fibrinoliticos de la uroquinasa, plasmidos para su preparacion y tromboliticos que los contienen.

Country Status (26)

Country Link
US (2) US5681721A (esLanguage)
EP (1) EP0669394B1 (esLanguage)
JP (1) JPH07143878A (esLanguage)
KR (1) KR960014346A (esLanguage)
CN (1) CN1057124C (esLanguage)
AT (1) ATE189261T1 (esLanguage)
AU (1) AU679512B2 (esLanguage)
CA (1) CA2127897A1 (esLanguage)
CZ (1) CZ288536B6 (esLanguage)
DE (2) DE4323754C1 (esLanguage)
DK (1) DK0669394T3 (esLanguage)
ES (1) ES2145075T3 (esLanguage)
FI (1) FI943354L (esLanguage)
GR (1) GR3032488T3 (esLanguage)
HR (1) HRP940366B1 (esLanguage)
HU (1) HU217101B (esLanguage)
IL (1) IL109107A0 (esLanguage)
NO (1) NO941561L (esLanguage)
NZ (1) NZ260991A (esLanguage)
PL (1) PL176971B1 (esLanguage)
PT (1) PT669394E (esLanguage)
RU (1) RU2143490C1 (esLanguage)
SI (1) SI0669394T1 (esLanguage)
SK (1) SK281586B6 (esLanguage)
UA (1) UA27132C2 (esLanguage)
ZA (1) ZA944202B (esLanguage)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4440892A1 (de) * 1994-11-17 1996-05-23 Gruenenthal Gmbh Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
DE4442665A1 (de) * 1994-11-30 1996-06-05 Gruenenthal Gmbh Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
CN1057125C (zh) * 1996-04-26 2000-10-04 南京大学 五种尿激酶变体基因及在大肠杆菌中的表达
CN1111739C (zh) * 1997-02-04 2003-06-18 许文俊 凝血、纤溶功能动态测定试剂
US6503947B1 (en) 1998-01-27 2003-01-07 Brigham And Women's Hospital Method of treating cytotoxic damage
US7498310B1 (en) 1998-08-13 2009-03-03 Beiersdorf Ag Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV radiation
AU2001269803A1 (en) * 2000-06-20 2002-01-02 The Trustees Of The University Of Pennsylvania Compositions and methods for modulating muscle cell and tissue contractility
US7361493B1 (en) 2004-05-26 2008-04-22 The United States Of America As Represented By The Secretary Of The Department Of Veterans Affairs Production of urokinase in a three-dimensional cell culture
CN102225966B (zh) 2004-10-19 2012-12-26 隆萨股份公司 用于固相肽合成的方法
CN104193807B (zh) * 2014-09-28 2016-06-15 广州贝奥吉因生物科技有限公司 凝血酶抑制多肽及其制备方法、应用
CN105385617A (zh) * 2015-09-23 2016-03-09 河北省科学院生物研究所 一株产纤溶酶的海洋放线菌株、用途以及由其制备的纤溶酶及纤溶酶的应用
JP2020501561A (ja) 2016-12-16 2020-01-23 ザ・ユニバーシティ・オブ・シドニー 脳卒中および関係する凝固性障害の処置のためのトロンビン阻害剤

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3930944A (en) * 1975-03-31 1976-01-06 Abbott Laboratories Urokinase production
DE3445517C2 (de) * 1984-12-13 1993-11-18 Ciba Geigy Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins
US4751180A (en) * 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US5002887A (en) * 1986-01-31 1991-03-26 Genetics Institute, Inc. Truncated thrombolytic proteins
WO1989001513A1 (fr) * 1987-08-19 1989-02-23 Sagami Chemical Research Center Prourokinase a action rapide
DE3804600A1 (de) * 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz
GB8822147D0 (en) * 1988-09-21 1988-10-26 Ciba Geigy Ag Pharmaceutically active combination
US5256770A (en) * 1990-04-09 1993-10-26 Schering Ag Oxidation resistant thrombomodulin analogs
EP0482069A1 (en) * 1989-07-20 1992-04-29 Biogen, Inc. Combinations and methods for treating or preventing thrombotic diseases
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5328898A (en) * 1990-06-22 1994-07-12 Duke University Factor XIIIA fibrin binding fragments
GB9015369D0 (en) * 1990-07-12 1990-08-29 Erba Carlo Spa Amidated fibrinolytic enzymes and their precursors,and processes for their preparation
US5242810A (en) * 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
AU1873092A (en) * 1991-04-09 1992-11-17 Brigham And Women's Hospital Chimeric molecule with plasminogen activator activity and affinity for atherosclerotic plaques
US5376367A (en) * 1991-11-22 1994-12-27 Immunex Corporation Fusion proteins comprising MGF and IL-3
US5571708A (en) * 1993-04-19 1996-11-05 Bristol-Myers Squibb Company Thrombin-activatable plasminogen activator
RU2061043C1 (ru) * 1993-11-16 1996-05-27 Научно-производственная фирма "Нарт" Способ повышения устойчивости урокиназы к нагреванию

Also Published As

Publication number Publication date
RU94026095A (ru) 1997-03-10
UA27132C2 (uk) 2000-02-28
PL176971B1 (pl) 1999-08-31
DE59409104D1 (de) 2000-03-02
ATE189261T1 (de) 2000-02-15
US5747291A (en) 1998-05-05
SI0669394T1 (en) 2000-04-30
FI943354A7 (fi) 1995-01-16
US5681721A (en) 1997-10-28
SK281586B6 (sk) 2001-05-10
HK1010109A1 (en) 1999-06-11
EP0669394B1 (de) 2000-01-26
PL304290A1 (en) 1995-01-23
ZA944202B (en) 1995-02-08
NO941561D0 (esLanguage) 1994-04-28
NZ260991A (en) 1995-10-26
FI943354L (fi) 1995-01-16
NO941561L (no) 1995-01-16
CA2127897A1 (en) 1995-01-16
AU6452594A (en) 1995-01-27
RU2143490C1 (ru) 1999-12-27
GR3032488T3 (en) 2000-05-31
HU9402063D0 (en) 1994-09-28
CZ170694A3 (en) 1995-02-15
KR960014346A (ko) 1996-05-22
HRP940366B1 (en) 2001-02-28
HU217101B (hu) 1999-11-29
DK0669394T3 (da) 2000-05-29
AU679512B2 (en) 1997-07-03
CN1102438A (zh) 1995-05-10
HUT70579A (en) 1995-10-30
EP0669394A1 (de) 1995-08-30
FI943354A0 (fi) 1994-07-14
DE4323754C1 (de) 1994-12-01
IL109107A0 (en) 1994-06-24
CN1057124C (zh) 2000-10-04
SK84594A3 (en) 1995-03-08
CZ288536B6 (cs) 2001-07-11
JPH07143878A (ja) 1995-06-06
HRP940366A2 (en) 1997-04-30
PT669394E (pt) 2000-07-31

Similar Documents

Publication Publication Date Title
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2115298T3 (es) Nuevos derivados de 1-fenil-3-dimetil-amino-propano, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2161697T3 (es) Peptidos agonistas de amilina y usos de los mismos.
MX9701497A (es) Polimeros de ioneno que contienen aniones biologicamente activos.
ES2018706B3 (es) Composicion polimera, un procedimiento para obtener una composicion polimera y el uso de dicha composicion.
ES536849A0 (es) Procedimiento para la obtencion de una composicion organopolisiloxanica.
ES519559A0 (es) Procedimiento para la obtencion de pirazolooxacinas, pirazolotiacinas y pirazoloquinolinas.
AR008991A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimientos para su preparacion y aplicacion de los mismos
ATE231872T1 (de) Thiazolopyrimidinderivate
MX9102500A (es) Compuestos de bifenilio, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2145075T3 (es) Nuevos derivados fibrinoliticos de la uroquinasa, plasmidos para su preparacion y tromboliticos que los contienen.
ES2023417B3 (es) Procedimiento para polimerizar una o mas 1-olefinas en fase gaseosa en presencia de material inorganico pulverulento.
ES2076595T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su empleo y agentes que los contienen.
ES500720A0 (es) Procedimiento para la construccion de una entibacion con an-clajes de galerias o tuneles
ES2014392A4 (es) Procedimiento para la fabricacion de peroxido de hidrogeno.
AR240814A1 (es) Nuevos derivados de acilamino-s-triazina, procedimiento para su preparacion y composiciones antiparasitarias que los contienen, excluida su actividad terapeutica.
NO860733L (no) N-(2-klor-4-trifluormethylfenyl)-3-trifluormethyl-benzensulfonamidderivat, fremgangsmaate for fremstilling av dette, og fungicid middel inneholdende dette.
AR002978A1 (es) Compuestos benzamidas, composiciones farmacéuticasque los contienen, metodos para preparar los mismos y el uso de los mismos.
IT8521945A0 (it) 2-piridilcarbossammide particolarmente per uso farmaceutico.
MX9207264A (es) Compuestos de sulfonimidamida, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
NO985079L (no) Eksplosiv formulering
IT8167585A0 (it) Composto chimico utilizzabile parti colarmente come agente farmaceutico antiulcera e procedimento per lasua fabbricazione
AU580890B2 (en) P-acylaminobenzamides
AR240317A1 (es) Procedimiento para la preparacion de pirimidinatrionas n-monosubtituidas-5,5-disubtituidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 669394

Country of ref document: ES